As DreamIt Ventures kicks off a call for applications for its second class of DreamIt Health in Philly, more and more applicants have smartphone diagnostic tools. This trend in mhealth …
The Food and Drug Administration has officially approved Breo Ellipta, a much-anticipated new treatment for chronic obstructive pulmonary disease. The inhaled drug was developed by GlaxoSmithKline and Theravance, and is …
The FDA grants 510(k) clearance to ResMed’s at-home respiratory device for patients with chronic obstructive pulmonary disease. ResMed out of San Diego, California won FDA clearance and is releasing its …
